EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Mycophenolic Acid Overcomes Imatinib and Nilotinib Resistance of Chronic Myeloid Leukemia Cells by Apoptosis or a Senescent-Like Cell Cycle Arrest

Claire Drullion, Valérie Lagarde, Romain Gioia, Patrick Legembre, Muriel Priault, Bruno Cardinaud, Eric Lippert, François-Xavier Mahon, Jean-Max Pasquet

Leukemia Research and Treatment · 2012

DOI: 10.1155/2012/861301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Leukemia Research and Treatment, 2012. Verfasst von Claire Drullion und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire Hématopoïèse Leucémique et Cibles Thérapeutiques, INSERM U1035, Université Bordeaux Ségalen, 146 Rue Léo Saignat Bat TP 4e étage, 33076 B…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We used K562 cells sensitive or generated resistant to imatinib or nilotinib to investigate their response to mycophenolic acid (MPA). MPA induced DNA damage leading to cell death with a minor contribution of apoptosis, as revealed by annexin V labeling (up to 25%). In contrast, cell cycle arrest and positive staining for senescence-associated β -galactosidase activity were detected for a large cell population (80%). MPA-induced cell death was potentialized by the inhibition of autophagy and this is associated to the upregulation of apoptosis. In contrast, senescence was neither decreased nor abrogated in autophagy deficient K562 cells. Primary CD34 cells from CML patients sensitive or resistant to imatinib or nilotinib respond to MPA although apoptosis is mainly detected. These results show that MPA is an interesting tool to overcome resistance in vitro and in vivo mainly in the evolved phase of the disease.

Autor:innen und Institutionen

  • Laboratoire Hématopoïèse Leucémique et Cibles Thérapeutiques, INSERM U1035, Université Bordeaux Ségalen, 146 Rue Léo Saignat Bat TP 4e étage, 33076 Bordeaux, France.

Zitieren

APA

Drullion, C., Lagarde, V., Gioia, R., Legembre, P., Priault, M., Cardinaud, B., Lippert, E., Mahon, F. X., & Pasquet, J. M. (2012). Mycophenolic Acid Overcomes Imatinib and Nilotinib Resistance of Chronic Myeloid Leukemia Cells by Apoptosis or a Senescent-Like Cell Cycle Arrest. Leukemia Research and Treatment. https://doi.org/10.1155/2012/861301

Vancouver

Drullion C, Lagarde V, Gioia R, Legembre P, Priault M, Cardinaud B, et al. Mycophenolic Acid Overcomes Imatinib and Nilotinib Resistance of Chronic Myeloid Leukemia Cells by Apoptosis or a Senescent-Like Cell Cycle Arrest. Leukemia Research and Treatment. 2012. doi:10.1155/2012/861301

BibTeX
@article{Drullion2012,
  author = {Drullion, Claire and Lagarde, Valérie and Gioia, Romain and Legembre, Patrick and Priault, Muriel and Cardinaud, Bruno and Lippert, Eric and Mahon, François-Xavier and Pasquet, Jean-Max},
  title = {Mycophenolic Acid Overcomes Imatinib and Nilotinib Resistance of Chronic Myeloid Leukemia Cells by Apoptosis or a Senescent-Like Cell Cycle Arrest},
  journal = {Leukemia Research and Treatment},
  year = {2012},
  doi = {10.1155/2012/861301}
}
Kostenlos starten →